The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Dengue: a continuing global threat
Open accessAbstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission
Hoffmann, A. A., Montgomery, B. L., Popovici, J., Iturbe-Ormaetxe, I., Johnson, P. H., Muzzi, F., Greenfield, M., Durkan, M., Leong, Y. S., Dong, Y., et al. (2011) · Nature · doi:10.1038/nature10356 · Cited by 1,603
The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations
Walker, T., Johnson, P. H., Moreira, L. A., Iturbe-Ormaetxe, I., Frentiu, F. D., McMeniman, C. J., Leong, Y. S., Dong, Y., Axford, J., Kriesner, P., et al. (2011) · Nature · doi:10.1038/nature10355 · Cited by 1,400
Antibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,205
Epidemiology of dengue: past, present and future prospects
Wilder-Smith, A., Murray, & Quam, M. (2013) · Clinical Epidemiology · doi:10.2147/clep.s34440 · Cited by 1,033
“13 Notably, in 2009, the Cape Verde archipelago had a large dengue outbreak involving more than 17,000 cases and linked to DENV-3.”
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Villar, L., Dayan, G. H., Arredondo-García, J. L., Rivera, D. M., Cunha, R., Deseda, C., Reynales, H., Costa, M. S., Morales-Ramírez, J. O., Carrasquilla, G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411037 · Cited by 942
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.-M., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 914
Guzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E., & Halstead, S. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.55 · Cited by 762
Self-citationGuzman, M. G., Alvarez, M., & Halstead, S. B. (2013) · Archives of Virology · doi:10.1007/s00705-013-1645-3 · Cited by 738
“Americas, Africa and the Mediterranean regions [58].”
Self-citationWilder-Smith, A., Ooi, E.-E., Horstick, O., & Wills, B. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32560-1 · Cited by 692
Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
Delgado-Rizo, V., Martínez-Guzmán, M. A., Iñiguez-Gutierrez, L., García-Orozco, A., Alvarado-Navarro, A., & Fafutis-Morris, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00081 · Cited by 686
“The incidence of dengue infections has increased in recent years (102); therefore, it is necessary to understand the mechanisms of host defense used to fight this pathogen.”
BackgroundThe Incubation Periods of Dengue Viruses
Chan, M., & Johansson, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050972 · Cited by 673
“Dengue viruses (DENV) are a major cause of illness, hospitalization, and death throughout the tropical and subtropical regions of the world [1].”
BackgroundWeiskopf, D., Angelo, M. A., de Azeredo, E. L., Sidney, J., Greenbaum, J. A., Fernando, A. N., Broadwater, A., Kolla, R. V., De Silva, A. D., de Silva, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305227110 · Cited by 615
“Suaya JA, et al. (2009) Cost of dengue cases in eight countries in the Americas and Asia: A prospective study.”
BackgroundMuller, D. A., & Young, P. R. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.008 · Cited by 572
“…infection and self-limiting febrile illness to encephalitis or meningitis or haemorrhage and shock, which can be fatal (Chappell et al., 2008; Guzman et al., 2010;…”
BackgroundClinical and Laboratory Diagnosis of Dengue Virus Infection
Muller, D. A., Depelsenaire, A. C. I., & Young, P. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw649 · Cited by 438
“Unlike the other flaviviruses, there are 4 serotypes, referred to as DENV1–4, that are genetically similar but antigenically distinct [2], defined by the inability of individually elicited antibodies to cross-neutralize.”
Bowman, L. R., Donegan, S., & McCall, P. J. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004551 · Cited by 449
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19…”
BackgroundEfficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents
Biswal, S., Reynales, H., Saez-Llorens, X., Lopez, P., Borja-Tabora, C., Kosalaraksa, P., Sirivichayakul, C., Watanaveeradej, V., Rivera, L., Espinoza, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903869 · Cited by 405
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
Manokaran, G., Finol, E., Wang, C., Gunaratne, J., Bahl, J., Ong, E. Z., Tan, H. C., Sessions, O. M., Ward, A. M., Gubler, D. J., et al. (2015) · Science · doi:10.1126/science.aab3369 · Cited by 412
Self-citationvan den Hurk, A. F., Hall-Mendelin, S., Pyke, A. T., Frentiu, F. D., McElroy, K., Day, A., Higgs, S., & O'Neill, S. L. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001892 · Cited by 416
“annually due to hemorrhagic disease [1].”
Santiago, G. A., Vergne, E., Quiles, Y., Cosme, J., Vazquez, J., Medina, J. F., Medina, F., Colón, C., Margolis, H., & Muñoz-Jordán, J. L. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002311 · Cited by 387
“Approximately 75% of DENV infections are acute, selfresolving, and asymptomatic [4].”
BackgroundSelf-citationA systematic review of mathematical models of mosquito-borne pathogen transmission: 1970–2010
Reiner, R. C., Perkins, T. A., Barker, C. M., Niu, T., Chaves, L. F., Ellis, A. M., George, D. B., Le Menach, A., Pulliam, J. R. C., Bisanzio, D., et al. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0921 · Cited by 381
“These include a renewed interest in malaria eradication [12], an expanding global dengue epidemic [13,14], the enormous global health burden of filariasis [15–18], outbreaks of chikungunya virus around the Indian Ocean [19], epidemics of Rift Valley Fever and concerns about its potential range…”
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
Reich, N. G., Shrestha, S., King, A. A., Rohani, P., Lessler, J., Kalayanarooj, S., Yoon, I.-K., Gibbons, R. V., Burke, D. S., & Cummings, D. A. T. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0414 · Cited by 350
Bowman, L. R., Runge-Ranzinger, S., & McCall, P. J. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002848 · Cited by 337
Dengue Virus Induces and Requires Glycolysis for Optimal Replication
Fontaine, K. A., Sanchez, E. L., Camarda, R., & Lagunoff, M. (2015) · Journal of Virology · doi:10.1128/jvi.02309-14 · Cited by 333
Guy, B., Barrere, B., Malinowski, C., Saville, M., Teyssou, R., & Lang, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.094 · Cited by 322
Dengue virus: A global human threat: Review of literature
Hasan, S., Jamdar, S., Alalowi, M., & Al Ageel Al Beaiji, S. (2016) · Journal of International Society of Preventive and Community Dentistry · doi:10.4103/2231-0762.175416 · Cited by 296
“[3‐5] Two and a half billion people reside in dengue‐endemic regions[5] and roughly 400 million infections occuring per year, with a mortality rate surpassing 5–20% in some areas.”
BackgroundLigand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation
Noble, C. G., Seh, C. C., Chao, A. T., & Shi, P. Y. (2012) · Journal of Virology · doi:10.1128/jvi.06225-11 · Cited by 301
“The four serotypes of DENV are estimated to cause 50 to 100 million human infections worldwide every year in tropical and subtropical regions (16).”
BackgroundAzeredo, E. L. D., Monteiro, R. Q., & de-Oliveira Pinto, L. M. (2015) · Mediators of Inflammation · doi:10.1155/2015/313842 · Cited by 288
“Using primary human endothelial cells (EC) infected with DENV isolated from DHF/DSS cases, Jiang et al. showed an increase in TF mRNA expression associated with a reduction in TFPI mRNA expression [140].”
BackgroundInfluentialDengue overview: An updated systemic review
Khan, M. B., Yang, Z.-S., Lin, C.-Y., Hsu, M.-C., Urbina, A. N., Assavalapsakul, W., Wang, W.-H., Chen, Y.-H., & Wang, S.-F. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.08.001 · Cited by 243
Sangkaew, S., Ming, D., Boonyasiri, A., Honeyford, K., Kalayanarooj, S., Yacoub, S., Dorigatti, I., & Holmes, A. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30601-0 · Cited by 278
Chen, R., & Vasilakis, N. (2011) · Viruses · doi:10.3390/v3091562 · Cited by 301
“Thus the global distribution of these two major vectors puts nearly a third of the global human population at risk of infection [8].”
BackgroundDengue and its effects on liver
Samanta, J. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i2.125 · Cited by 271
Chan, E. H., Sahai, V., Conrad, C., & Brownstein, J. S. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001206 · Cited by 284
“borne diseases [2,3].”
Tricou, V., Yu, D., Reynales, H., Biswal, S., Saez-Llorens, X., Sirivichayakul, C., Lopez, P., Borja-Tabora, C., Bravo, L., Kosalaraksa, P., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00522-3 · Cited by 268
Flaviviruses and flavivirus vaccines
Heinz, F. X., & Stiasny, K. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.09.114 · Cited by 268
“For instance, infection with any one of the four DENV erotypes induces life-long protection against the same serotype ut only for few months against the other serotypes [6].”
BackgroundBiswal, S., Borja-Tabora, C., Martinez Vargas, L., Velásquez, H., Theresa Alera, M., Sierra, V., Johana Rodriguez-Arenales, E., Yu, D., Wickramasinghe, V. P., Duarte Moreira, E., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30414-1 · Cited by 263
Low, J. G., Sung, C., Wijaya, L., Wei, Y., Rathore, A. P. S., Watanabe, S., Tan, B. H., Toh, L., Chua, L. T., Hou, Y., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70730-3 · Cited by 253
Estratégias de controle do Aedes aegypti: uma revisão
Laura de Sene Amâncio Zara, A., Maria dos Santos, S., Synthia Fernandes-Oliveira, E., Gomes Carvalho, R., & Evelim Coelho, G. (2016) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742016000200017 · Cited by 200
“Além do impacto ambiental, a desvantagem está no alto custo dos piretroides.(26,30,39,40) O monitoramento da susceptibilidade a inseticidas em diferentes áreas do país é uma estratégia racional importante para ampliar o conhecimento sobre os mecanismos de resistência e para o controle dos níveis de infestação vetorial…”
BackgroundMackey, T. K., Liang, B. A., Cuomo, R., Hafen, R., Brouwer, K. C., & Lee, D. E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00045-14 · Cited by 249
“This may reflect viral evolution toward greater virulence, potentially from patient reinfection by one of the now five different dengue virus serotypes, which results in only partial immunity (9, 159, 168).”
BackgroundNeurological Manifestations of Dengue Infection
Li, G.-H., Ning, Z.-J., Liu, Y.-M., & Li, X.-H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00449 · Cited by 232
“About 2.5% of all diseased people die (Guzman et al., 2010; Bhatt et al., 2013).”
BackgroundInfluentialFactors Associated with Dengue Shock Syndrome: A Systematic Review and Meta-Analysis
Huy, N. T., Van Giang, T., Thuy, D. H. D., Kikuchi, M., Hien, T. T., Zamora, J., & Hirayama, K. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002412 · Cited by 223
“It is thought that normal nutrition is a risk factor of DSS, while malnutrition is a protective factor due to suppressed immune activation in malnourished children [12,13,14].”
BackgroundAnimal Models of Dengue Virus Infection
Zompi, S., & Harris, E. (2012) · Viruses · doi:10.3390/v4010062 · Cited by 230
“Finally, endemic areas have been reported in the Eastern Mediterranean [5,6].”
BackgroundInnate Immunity to Dengue Virus Infection and Subversion of Antiviral Responses
Green, A. M., Beatty, P. R., Hadjilaou, A., & Harris, E. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.11.023 · Cited by 219
“recently estimated that up to 96 million dengue cases and a total of 390 million DENV infections occur each year worldwide [3], leading to approximately 500,000 hospitalizations and 25,000 deaths, primarily among children [4].”
Assessing the Effects of Aedes aegypti kdr Mutations on Pyrethroid Resistance and Its Fitness Cost
Brito, L. P., Linss, J. G. B., Lima-Camara, T. N., Belinato, T. A., Peixoto, A. A., Lima, J. B. P., Valle, D., & Martins, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060878 · Cited by 215
“important arthropod-borne viral infection of man [3].”
CLEC5A is critical for dengue virus–induced inflammasome activation in human macrophages
Wu, M.-F., Chen, S.-T., Yang, A.-H., Lin, W.-W., Lin, Y.-L., Chen, N.-J., Tsai, I.-S., Li, L., & Hsieh, S.-L. (2013) · Blood · doi:10.1182/blood-2012-05-430090 · Cited by 210
“diseases in tropical and subtropical areas with approximately 50 million cases occurring annually.(1,2) Even though most patients infected by DV are asymptomatic, DV infection can cause a wide spectrum of clinical symptoms, ranging from dengue fever (DF) to dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS).”
BackgroundHanley, K. A., Monath, T. P., Weaver, S. C., Rossi, S. L., Richman, R. L., & Vasilakis, N. (2013) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.03.008 · Cited by 212
“The overall burden of dengue disease in the Americas is currently estimated to be 99–1300 disability adjusted life years (DALYs) per million, depending on the spatiotemporal attributes of epidemics (Guzman et al., 2010; Luz et al., 2009; Mathers et al., 2007; Torres and Castro, 2007; Wettstein et al., 2012), imposing…”
Differential Targeting of Viral Components by CD4+versus CD8+T Lymphocytes in Dengue Virus Infection
Rivino, L., Kumaran, E. A. P., Jovanovic, V., Nadua, K., Teo, E. W., Pang, S. W., Teo, G. H., Gan, V. C. H., Lye, D. C., Leo, Y. S., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02675-12 · Cited by 203
Chao, C.-H., Wu, W.-C., Lai, Y.-C., Tsai, P.-J., Perng, G.-C., Lin, Y.-S., & Yeh, T.-M. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007625 · Cited by 200
The changing incidence of Dengue Haemorrhagic Fever in Indonesia: a 45-year registry-based analysis
Karyanti, M. R., Uiterwaal, C. S. P. M., Kusriastuti, R., Hadinegoro, S. R., Rovers, M. M., Heesterbeek, H., Hoes, A. W., & Bruijning-Verhagen, P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-412 · Cited by 193
“%) in Southeast Asia and the Western Pacific Region [1-4].”
BackgroundGrange, L., Simon-Loriere, E., Sakuntabhai, A., Gresh, L., Paul, R., & Harris, E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00280 · Cited by 195
“There is some suggestion that primary (1°) DENV infections can be majoritarily inapparent in certain outbreaks (16), whereas secondary (2°) infections lead to more severe symptoms even when occurring 20 years later (17).”
Backgroundde Alwis, R., Williams, K. L., Schmid, M. A., Lai, C.-Y., Patel, B., Smith, S. A., Crowe, J. E., Wang, W.-K., Harris, E., & de Silva, A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004386 · Cited by 194
“common arthropod-borne viral disease of humans [1,2].”
BackgroundMurugesan, A., & Manoharan, M. (2020) · Emerging and Reemerging Viral Pathogens · doi:10.1016/b978-0-12-819400-3.00016-8 · Cited by 163
Sánchez-Purrà, M., Carré-Camps, M., de Puig, H., Bosch, I., Gehrke, L., & Hamad-Schifferli, K. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00110 · Cited by 187
Akbari, O. S., Antoshechkin, I., Amrhein, H., Williams, B., Diloreto, R., Sandler, J., & Hay, B. A. (2013) · G3: Genes, Genomes, Genetics · doi:10.1534/g3.113.006742 · Cited by 194
“The range of A. aegypti is expanding through tropical and subtropical zones worldwide, and the occurrence of Dengue fever has closely followed the expansion of the mosquitoes (Guzman et al. 2010; Guzman and Isturiz 2010; Lounibos 2002).”
BackgroundDengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis
Paixão, E. S., Teixeira, M. G., Costa, M. D. C. N., & Rodrigues, L. C. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00088-8 · Cited by 180
Schoggins, J. W., Dorner, M., Feulner, M., Imanaka, N., Murphy, M. Y., Ploss, A., & Rice, C. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212379109 · Cited by 183
“Each year, over 50 million people are affected by dengue fever, and ∼500,000 are hospitalized with the more severe dengue hemorrhagic fever (1).”
BackgroundThe Impact of the Newly Licensed Dengue Vaccine in Endemic Countries
Aguiar, M., Stollenwerk, N., & Halstead, S. B. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005179 · Cited by 177
Self-citationMathematical models for dengue fever epidemiology: A 10-year systematic review
Aguiar, M., Anam, V., Blyuss, K. B., Estadilla, C. D. S., Guerrero, B. V., Knopoff, D., Kooi, B. W., Srivastav, A. K., Steindorf, V., & Stollenwerk, N. (2022) · Physics of Life Reviews · doi:10.1016/j.plrev.2022.02.001 · Cited by 163
“When the short-term cross-protection wanes, patients experiencing a secondary heterologous dengue virus infection are at higher risk of severe disease [15, 17–22], via the so-called ADE process [15,18,21,23,24].”
Mathematical analysis of dengue fever outbreak by novel fractional operators with field data
Qureshi, S., & Atangana, A. (2019) · Physica A: Statistical Mechanics and its Applications · doi:10.1016/j.physa.2019.121127 · Cited by 174
Metal Compounds against Neglected Tropical Diseases
Ong, Y. C., Roy, S., Andrews, P. C., & Gasser, G. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00338 · Cited by 177
Flavivirus-Mosquito Interactions
Huang, Y.-J., Higgs, S., Horne, K., & Vanlandingham, D. (2014) · Viruses · doi:10.3390/v6114703 · Cited by 173
“In the 1970s, only nine countries were considered endemic for DENV, currently there are more than 100 countries in Southeast Asia, Latin America, and the Western Pacific region affected by DENV [96].”
BackgroundDengue vaccine: hypotheses to understand CYD-TDV-induced protection
Guy, B., & Jackson, N. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.2 · Cited by 175
Kittayapong, P., Ninphanomchai, S., Limohpasmanee, W., Chansang, C., Chansang, U., & Mongkalangoon, P. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007771 · Cited by 177
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Guy, B., Briand, O., Lang, J., Saville, M., & Jackson, N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.108 · Cited by 172
Blacksell, S. D. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/151967 · Cited by 167
“This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
MethodLinss, J., Brito, L. P., Garcia, G. A., Araki, A. S., Bruno, R. V., Lima, J. B. P., Valle, D., & Martins, A. J. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-25 · Cited by 167
“It has been previously observed that in Latin America the 1016 Ile kdr is highly disseminated [12,15,16] and its frequency is rapidly increasing in localities with intense pyrethroid use, such as Brazil and Mexico [15,16].”
BackgroundInfluentialRathore, A. P. S., Paradkar, P. N., Watanabe, S., Tan, K. H., Sung, C., Connolly, J. E., Low, J., Ooi, E. E., & Vasudevan, S. G. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.10.002 · Cited by 165
“Infection of humans by any of the four DENV serotypes leads to an incubation period ranging from 3 to 14 days (average 4–7 days) followed by the rapid onset of clinical manifestations of DF (Guzman et al., 2010; Halstead, 2007).”
BackgroundNitsche, C., Schreier, V. N., Behnam, M. A. M., Kumar, A., Bartenschlager, R. F. W., & Klein, C. D. P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400828u · Cited by 163
Yang, X., Yang, S., Li, Q., Wuchty, S., & Zhang, Z. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.005 · Cited by 165
“World-wide dengue fever cases have continuously increased in recent decades [1], pointing to 50 million annual cases that cause 25,000 deaths [2,3].”
BackgroundWolbachia Reduces the Transmission Potential of Dengue-Infected Aedes aegypti
Ye, Y. H., Carrasco, A. M., Frentiu, F. D., Chenoweth, S. F., Beebe, N. W., van den Hurk, A. F., Simmons, C. P., O’Neill, S. L., & McGraw, E. A. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003894 · Cited by 164
“Dengue viruses (DENVs) causes a spectrum of symptoms ranging from a mild fever to the life-threatening dengue shock syndrome [1–4] and collectively has become the most prevalent arthropod-borne viruses affecting humans today [5,6].”
BackgroundSelf-citationLowe, R., Barcellos, C., Coelho, C. A. S., Bailey, T., Coelho, G. E., Graham, R., Jupp, T. E., Ramalho, W. M., Carvalho, M. S., Stephenson, D. B., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70781-9 · Cited by 163
Biochemistry and Medicinal Chemistry of the Dengue Virus Protease
Nitsche, C., Holloway, S., Schirmeister, T., & Klein, C. D. (2014) · Chemical Reviews · doi:10.1021/cr500233q · Cited by 158
Smith, S. A., Zhou, Y., Olivarez, N. P., Broadwater, A. H., de Silva, A. M., & Crowe, J. E. (2012) · Journal of Virology · doi:10.1128/jvi.06335-11 · Cited by 161
“tion is at risk of infection by DENV (9, 12, 13).”
BackgroundNovel Dengue Virus NS2B/NS3 Protease Inhibitors
Wu, H., Bock, S., Snitko, M., Berger, T., Weidner, T., Holloway, S., Kanitz, M., Diederich, W. E., Steuber, H., Walter, C., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03543-14 · Cited by 156
Temephos Resistance in Aedes aegypti in Colombia Compromises Dengue Vector Control
Grisales, N., Poupardin, R., Gomez, S., Fonseca-Gonzalez, I., Ranson, H., & Lenhart, A. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002438 · Cited by 155
“Approximately 50 million infections occur in 100 countries annually [1,2], and 60% of those are estimated to occur in the Americas [3].”
BackgroundSerum Metabolome and Lipidome Changes in Adult Patients with Primary Dengue Infection
Cui, L., Lee, Y. H., Kumar, Y., Xu, F., Lü, K., Ooi, E. E., Tannenbaum, S. R., & Ong, C. N. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002373 · Cited by 175
“Furthermore, DENV has spread widely, and all four serotypes are now circulating in Asia, Africa and the Americas [3].”
BackgroundFlaviviruses and their antigenic structure
Heinz, F. X., & Stiasny, K. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.08.024 · Cited by 151
Dengue Situation in Bangladesh: An Epidemiological Shift in terms of Morbidity and Mortality
Mutsuddy, P., Jhora, S. T., Shamsuzzaman, A. K. M., Kaisar, S. M. G., & Khan, M. N. A. (2019) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2019/3516284 · Cited by 151
Kikuti, M., da Cunha, G. M., Paploski, I. A. D., Kasper, A. M., Silva, M. M. O., Tavares, A. S., Cruz, J. S., de Queiroz, T. L., Rodrigues, M. M. D. S., Santana, P. M., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003937 · Cited by 184
Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides
Pujol, C. A., Ray, S., Ray, B., & Damonte, E. B. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.05.028 · Cited by 143
Coller, B.-A., Clements, D. E., Bett, A. J., Sagar, S. L., & ter Meulen, J. H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.021 · Cited by 142
“Furthermore, while the more severe forms of the disease occur relatively infrequently (< 5%), the vast majority of DHF cases occur following secondary infection [1, 4, 5].”
BackgroundCurrent Trends and Limitations in Dengue Antiviral Research
Obi, J. O., Gutiérrez-Barbosa, H., Chua, J. V., & Deredge, D. J. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6040180 · Cited by 145
Dengue Detection: Advances in Diagnostic Tools from Conventional Technology to Point of Care
Kabir, M. A., Zilouchian, H., Younas, M. A., & Asghar, W. (2021) · Biosensors · doi:10.3390/bios11070206 · Cited by 151
Aubry, F., Nougaırède, A., Gould, E. A., & de Lamballerie, X. N. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.007 · Cited by 154
“These viruses cause millions of human infections each year ranging from mild febrile symptoms to fatal hemorrhagic/neurologic disease (Gubler, 2002; Guzman et al., 2010; Halstead and Thomas, 2010; Hayes et al., 2005; Monath, 2008) .”
BackgroundIgM in human immunity to Plasmodium falciparum malaria
Boyle, M. J., Chan, J.-A., Handayuni, I., Reiling, L., Feng, G., Hilton, A., Kurtovic, L., Oyong, D. A., Piera, K. A., Barber, B. E., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax4489 · Cited by 139
Role of the Vector in Arbovirus Transmission
Conway, M. J., Colpitts, T. M., & Fikrig, E. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085513 · Cited by 174
“5 billion individuals or 40% of the world population, making DENV a significant burden on these struggling economies (3).”
BackgroundDengue virus pathogenesis and host molecular machineries
Sinha, S., Singh, K., Kumar, Y., Roy, R., Phadnis, S., Meena, V., Bhattacharyya, S., & Verma, B. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01030-9 · Cited by 137
Inflammatory and Innate Immune Responses in Dengue Infection
Costa, V. V., Fagundes, C. T., Souza, D. G., & Teixeira, M. M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.027 · Cited by 140
The dengue situation in Africa
Were, F. (2012) · Paediatrics and International Child Health · doi:10.1179/2046904712z.00000000048 · Cited by 137
Development and characterization of a stable luciferase dengue virus for high-throughput screening
Zou, G., Xu, H. Y., Qing, M., Wang, Q.-Y., & Shi, P. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.05.001 · Cited by 138
de la Cruz, L., Nguyen, T. H. D., Ozawa, K., Shin, J., Graham, B., Huber, T., & Otting, G. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208435s · Cited by 134
Mairiang, D., Zhang, H., Sodja, A., Murali, T., Suriyaphol, P., Malasit, P., Limjindaporn, T., & Finley, R. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053535 · Cited by 149
“thousands of deaths, especially in children [2].”
Chen, J., Ng, M. L., & Chu, J. J. H. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005053 · Cited by 142
“DV NS1 protein can be detected for a longer period of time in the sera of dengue patients compared to DV [91].”
ResultAngleró-Rodríguez, Y., MacLeod, H. J., Kang, S., Carlson, J. S., Jupatanakul, N., & Dimopoulos, G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02050 · Cited by 133
“DENV causes 400 million infections and 12,500 deaths per year, and ZIKV recently emerged as another arbovirus of major public health concern (Guzman et al., 2010; WHO, 2012; Bhatt et al., 2013; Weaver et al., 2016).”
BackgroundThe dengue vaccine pipeline: Implications for the future of dengue control
Schwartz, L. M., Halloran, M. E., Durbin, A. P., & Longini, I. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.010 · Cited by 132
“People who have had a single primary infection have been observed to have a higher risk of severe dengue including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) upon a second infection, a phenomenon often attributed to antibody enhancement [5].”
BackgroundPopulation bottlenecks and founder effects: implications for mosquito-borne arboviral emergence
Weaver, S. C., Forrester, N. L., Liu, J., & Vasilakis, N. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00482-8 · Cited by 159
Simple Clinical and Laboratory Predictors of Chikungunya versus Dengue Infections in Adults
Lee, V. J., Chow, A. L., Zheng, X., Carrasco, L. R., Cook, A. R., Lye, D. C., Ng, L. C., & Leo, Y. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001786 · Cited by 150
“epidemics in Africa, India, Sri Lanka and Southeast Asia [3], and dengue in most tropical and subtropical regions of the world [32].”
BackgroundUSP14: Structure, Function, and Target Inhibition
Wang, F., Ning, S., Yu, B., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.801328 · Cited by 153
“…Arrested cell cycle and decreased the lung cell proliferation, migration, and invasion Shu et al. (2011); Wu et al. (2013); Zhu et al. (2016b); Han et al. (2019) Gastric cancer (GC) USP14 stabilize the oncoprotein vimentin Akt and ERK signaling pathways Increased sensitivity of GC cells to…”
BackgroundInfluentialHydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
Wang, L.-F., Lin, Y.-S., Huang, N., Yu, C.-Y., Tsai, W.-L., Chen, J., Kubota, T., Matsuoka, M., Chen, S.-R., Yang, C.-S., et al. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0038 · Cited by 127
Ferreira, D. A. D. C., Degener, C. M., Marques-Toledo, C., Bendati, M. M. D. A., Fetzer, L. O., Teixeira, C. P., & Eiras, Á. E. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2025-8 · Cited by 132
“The disease has expanded geographically in recent years, so that all four dengue virus serotypes (DENV 1–4) are now circulating in Asia, Africa and the Americas [4], and autochthonous dengue transmission has recently reached southern regions of North America and Europe [5, 6].”
BackgroundWhy are people with dengue dying? A scoping review of determinants for dengue mortality
Carabalí, M., Hernández, L. M., Arauz, M. J., Villar, L. A., & Ridde, V. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1058-x · Cited by 126
“Lack of economic resources is often associated with the presence of dengue [1, 6, 7, 19, 109].”
BackgroundInfluential
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.